Delving into the Latest Updates on Nisshin Flour Milling Co Ltd with Synapse

概览

关联

5

项与 Nisshin Flour Milling Co Ltd 相关的药物

NS-3601

靶点

PDE x Potassium channel x calcium channel

作用机制

PDE inhibitors [+2]

在研机构-

原研机构

Nisshin Flour Milling Co Ltd

在研适应症-

非在研适应症

心脏病

最高研发阶段终止

首次获批国家/地区-

首次获批日期-

N-3393

靶点-

作用机制

一氧化氮刺激剂 [+1]

在研机构-

原研机构

Nisshin Flour Milling Co Ltd

在研适应症-

非在研适应症

神经系统变性病 [+1]

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

N-3256

靶点

5-HT3 receptor

作用机制

5-HT3 receptor拮抗剂

在研机构-

原研机构

Nisshin Flour Milling Co Ltd

在研适应症-

非在研适应症

呕吐

最高研发阶段无进展

首次获批国家/地区-

首次获批日期-

100 项与 Nisshin Flour Milling Co Ltd 相关的临床结果

登录后查看更多信息

0 项与 Nisshin Flour Milling Co Ltd 相关的专利（医药）

登录后查看更多信息

166

项与 Nisshin Flour Milling Co Ltd 相关的文献（医药）

2006-05-01·Brazilian Archives of Biology and Technology

Production of alcohol by simultaneous saccharification and fermentation of low-grade wheat flour

作者: Neves, Marcos Antonio das ; Shiiba, Kiwamu ; Shimizu, Naoto ; Kimura, Toshinori

Two samples of low-grade wheat flour, namely low-grade 1 (LG1) and low-grade 2 (LG2), with different carbohydrate and fibrous content, were used as substrates. The samples were liquefied using various concentrations of alpha- or beta-amylase, in order to optimize the production of fermentable sugars; the enzyme alpha-amylase revealed higher performance. After liquefaction, the simultaneous saccharification and fermentation was conducted in a jar fermentor. Amyloglucosidase was used for saccharification, and dry baker's yeast, S. cerevisiae, for fermentation simultaneously. Glucose was consumed promptly in both cases, LG1 and LG2; ethanol production was considerably higher in LG1 (38.6 g/L), compared to LG2 (24.9 g/L). The maximum ATP production was observed early in the SSF process. LG1 revealed higher potential as substrate for ethanol production.

2005-01-01·Journal of the Society of Powder Technology, Japan

乾式サイクロンの局所的な流動制御による分級性能の向上

作者: Hideto Yoshida ; Kouichiro Ono ; Satoshi Akiyama ; Yuta Inada ; Ryota Nobukiyo ; Kunihiro Fukui

The present work studied the effectiveness of secondary flow injection into a cyclone on the separation performance of sub-micron particles.The particle collection efficiency increased with the secondary flowrate when injected in the upper cylindrical section of the cyclone.It was found that high particle collection efficiency is attained when the injection location of the secondary flow is close to the upper plate at a high flow velocity.A new type of cyclone developed based on these results achieved a high collection efficiency, which was in qual. agreement with the three-dimensional simulation results.

2003-01-01·KAGAKU KOGAKU RONBUNSHU

Control of Product Particle Size by Closed-circuit Pulverization System.

作者: Fukui, Kunihiro ; Kanemoto, Hiroaki ; Miyatake, Atsushi ; Yoshida, Hideto ; Shinoda, Eiji

Exptl. and theor. studies were conducted on the control of product particle size distribution by use of a closed-circuit pulverization system.The performance of a pin mill type pulverizer and a rotational blade type classifier were modeled by use of exptl. data.The returning powder flow rate was taken into consideration and material balance equations of each size range were numerically solved by an iterative method.When the median particle diameter of the product is constant, it is necessary to set a low rotational speed of classifier and a high rotational speed of pulverizer for low return ratio region.The opposite condition is applied to the high return ratio region.Under the condition of constant median diameter of product, the standard deviation shows the min. value when the return ratio equals one.For the return ratio less than one, increase of cut size of the classifier produces a large standard deviation.For a return ratio greater than one, the decrease of rotational speed of pulverizer is the main reason to the increased standard deviation of the product particle.

100 项与 Nisshin Flour Milling Co Ltd 相关的药物交易

登录后查看更多信息

100 项与 Nisshin Flour Milling Co Ltd 相关的转化医学

登录后查看更多信息

组织架构

使用我们的机构树数据加速您的研究。

登录

或

查看完整样例数据

管线布局

2024年12月23日管线快照

管线布局中药物为当前组织机构及其子机构作为药物机构进行统计，早期临床1期并入临床1期，临床1/2期并入临床2期，临床2/3期并入临床3期

其他

5

登录后查看更多信息

当前项目

药物(靶点)	适应症	全球最高研发状态

NS-3601 ( PDE x Potassium channel x calcium channel )	心脏病更多	终止
N-3256 ( 5-HT3 receptor )	呕吐更多	无进展
N-2733 ( TNF-α )	脓毒症更多	无进展
N-3393	脑卒中更多	无进展
N-4909	高胆固醇血症更多	无进展